Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3800373
rs3800373
0.010 GeneticVariation BEFREE rs3800373 FKBP5 may increase the risk of developing predominantly depressed BPD, probably through the creation of an enhancer consensus sequence in the 3'UTR of the gene, thus potentially increasing its expression. 31071710

2019

dbSNP: rs1440306
rs1440306
A 0.800 GeneticVariation GWASCAT A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013

dbSNP: rs1440306
rs1440306
A 0.800 GeneticVariation GWASDB A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013

dbSNP: rs556493
rs556493
A 0.800 GeneticVariation GWASDB A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013

dbSNP: rs556493
rs556493
A 0.800 GeneticVariation GWASCAT A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013

dbSNP: rs72791417
rs72791417
A 0.800 GeneticVariation GWASCAT A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013

dbSNP: rs72791417
rs72791417
A 0.800 GeneticVariation GWASDB A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013

dbSNP: rs3093059
rs3093059
CRP
0.010 GeneticVariation BEFREE A number of other SNPs in the CRP region, including rs3093059, had nominal associations with BPD. 28839172

2017

dbSNP: rs6313
rs6313
0.010 GeneticVariation BEFREE A number of studies have assessed a relationship between the T102C polymorphism in the HTR2A gene with an increased risk of major depressive disorder (MDD), bipolar disorder (BPD), and schizophrenia (SCZ). 24962835

2014

dbSNP: rs5744168
rs5744168
0.010 GeneticVariation BEFREE A TLR5 (g.1174C > T) variant that encodes a stop codon (R392X) is associated with bronchopulmonary dysplasia. 22058078

2012

dbSNP: rs2664352
rs2664352
0.010 GeneticVariation BEFREE After adjustment for birth weight and ethnic origin, the TT genotype of MMP16 C/T (rs2664352) and the GG genotype of MMP16 A/G (rs2664349) were found to protect from BPD. 18784838

2008

dbSNP: rs2664349
rs2664349
0.010 GeneticVariation BEFREE After adjustment for birth weight and ethnic origin, the TT genotype of MMP16 C/T (rs2664352) and the GG genotype of MMP16 A/G (rs2664349) were found to protect from BPD. 18784838

2008

dbSNP: rs11199993
rs11199993
0.010 GeneticVariation BEFREE After correcting the multiple tests by permutation, one SNP (rs11199993), and a haplotype including this SNP, was found to be significantly associated with BPD. 22404656

2012

dbSNP: rs2230912
rs2230912
0.020 GeneticVariation BEFREE After correction for multiple testing, the association between rs2230912 and HADS-depression score remained significant in the BPD group (p<0.006); this genetic effect explained 9% of the variance (partial η(2)=0.09). 23602648

2013

dbSNP: rs397507444
rs397507444
0.020 GeneticVariation BEFREE Although MTHFR A1298C was not significantly associated with the combination of major psychiatric disorders, nor with SZ, there was evidence for diagnostic moderation indicating a significant association with BPD (random effects OR=2.03 for AA versus CC genotype carriers, CI: 1.07-3.86). 21185933

2011

dbSNP: rs2709370
rs2709370
0.010 GeneticVariation BEFREE Although the associations of both CREB1 SNPs with each illness were not replicated in the new cohorts (BPD analysis in 871 cases and 1089 controls (rs2709370, P=0.0611; rs6785, P=0.0544); SCZ analysis in 1273 cases and 1072 controls (rs2709370, P=0.230; rs6785, P=0.661); and MDD analysis in 129 cases and 100 controls (rs2709370, P=0.114; rs6785, P=0.188)), an overall meta-analysis of all included samples suggested that both SNPs were significantly associated with increased risk of BPD (11 105 cases and 51 331 controls; rs2709370, P=2.33 × 10<sup>-4</sup>; rs6785, P=6.33 × 10<sup>-5</sup>), SCZ (34 913 cases and 44 528 controls; rs2709370, P=3.96 × 10<sup>-5</sup>; rs6785, P=2.44 × 10<sup>-5</sup>) and MDD (9369 cases and 9619 controls; rs2709370, P=0.0144; rs6785, P=0.0314), with the same direction of allelic effects across diagnostic categories. 29158582

2018

dbSNP: rs7975
rs7975
0.010 GeneticVariation BEFREE Among early-onset patients, the variant alleles of Glu32Lys and G-1002A increased BPD susceptibility. 22374552

2012

dbSNP: rs1800450
rs1800450
0.010 GeneticVariation BEFREE An association was found between two SNPs and the development of bronchopulmonary dysplasia (BPD), defined as persistent oxygen requirement at 36 weeks postmenstrual age, adjusting for covariates GA, grade of respiratory distress syndrome and days on mechanical ventilation (rs1800450 (exon 1 at codon 54, B variant): odds ratio dominant model (OR)=3.59, 95% confidence interval (CI)=1.62-7.98; rs7096206 (-221, X variant): OR=2.40, 95% CI=1.16-4.96). 17898783

2007

dbSNP: rs7096206
rs7096206
0.010 GeneticVariation BEFREE An association was found between two SNPs and the development of bronchopulmonary dysplasia (BPD), defined as persistent oxygen requirement at 36 weeks postmenstrual age, adjusting for covariates GA, grade of respiratory distress syndrome and days on mechanical ventilation (rs1800450 (exon 1 at codon 54, B variant): odds ratio dominant model (OR)=3.59, 95% confidence interval (CI)=1.62-7.98; rs7096206 (-221, X variant): OR=2.40, 95% CI=1.16-4.96). 17898783

2007

dbSNP: rs372271081
rs372271081
0.700 GeneticVariation GWASCAT Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants. 30113228

2018

dbSNP: rs2781666
rs2781666
0.010 GeneticVariation BEFREE Arginase I SNP (rs2781666) may be associated with protection against pulmonary hypertension in preterm neonates with BPD. 24919409

2014

dbSNP: rs174576
rs174576
0.010 GeneticVariation BEFREE Aside from replicating previously reported BPD risk SNPs, we herein also report several intriguing findings: (1) the SNP rs174576 was associated with BPD in our Chinese sample and in the overall global meta-analysis, and was significantly correlated with FADS1 mRNA in diverse public RNA-seq datasets as well as our in house collected Chinese amygdala samples; (2) two (partially) independent SNPs in MAD1L1 were both significantly associated with BPD in our Chinese sample, which was also supported by haplotype analysis; (3) a rare SNP rs78089757 in 10q26.13 region was a genome-wide significant variant for BPD in East Asians, and this SNP was near monomorphic in Europeans. 30531795

2018

dbSNP: rs78089757
rs78089757
0.010 GeneticVariation BEFREE Aside from replicating previously reported BPD risk SNPs, we herein also report several intriguing findings: (1) the SNP rs174576 was associated with BPD in our Chinese sample and in the overall global meta-analysis, and was significantly correlated with FADS1 mRNA in diverse public RNA-seq datasets as well as our in house collected Chinese amygdala samples; (2) two (partially) independent SNPs in MAD1L1 were both significantly associated with BPD in our Chinese sample, which was also supported by haplotype analysis; (3) a rare SNP rs78089757 in 10q26.13 region was a genome-wide significant variant for BPD in East Asians, and this SNP was near monomorphic in Europeans. 30531795

2018

dbSNP: rs187269
rs187269
0.010 GeneticVariation BEFREE Disease-control differences were significantly correlated with SNP rs187269 in BPD males for both beta(2S1) and beta(2S2) expressions, and significantly correlated with SNPs rs2546620 and rs187269 in SCZ males for beta(2S2) expression. 19763268

2009

dbSNP: rs2546620
rs2546620
0.010 GeneticVariation BEFREE Disease-control differences were significantly correlated with SNP rs187269 in BPD males for both beta(2S1) and beta(2S2) expressions, and significantly correlated with SNPs rs2546620 and rs187269 in SCZ males for beta(2S2) expression. 19763268

2009